GlassScriptPhysician profile
Phillip Sasso
NPI 1831191089
$31,521.30
in general payments reported to CMS, 2019-2025
64 companies · $3,334 in 2025
The $3,334 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,096 · 2020: $4,473 · 2021: $4,677 · 2022: $6,690 · 2023: $4,567 · 2024: $3,683 · 2025: $3,334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Education: $39.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,545.24 |
| Education | $39.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $14,700.63 | 2019-2025 | Proclaim, Eterna, Octrode |
| Boston Scientific Corporation | $3,918.03 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Vertos Medical, INC. | $2,693.52 | 2019-2024 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $2,014.79 | 2019-2025 | Xtampza, Belbuca |
| Abbvie INC. | $839.00 | 2021-2025 | Ubrelvy, Qulipta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $739.34 | 2019-2025 | Relistor |
| Scilex Pharmaceuticals INC. | $729.22 | 2021-2025 | Ztlido |
| Medtronic, INC. | $414.82 | 2021-2025 | Inceptiv, Intellis Adaptivestim |
| Ibsa Pharma INC. | $399.82 | 2022-2025 | Tirosint, Licart, Tirosint |
| Valinor Pharma, LLC | $338.88 | 2023-2025 | Movantik |
| Foundation Fusion Solutions, LLC | $317.25 | 2020-2025 | |
| Teva Pharmaceuticals USA, INC. | $296.91 | 2023-2025 | Austedo Xr, Austedo, Austedo Xr |
| Pfizer INC. | $278.98 | 2023-2025 | |
| Vertex Pharmaceuticals Incorporated | $275.36 | 2024-2025 | |
| Averitas Pharma INC. | $268.50 | 2023-2025 | Qutenza |
Show all 64 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $233.05 | 2019-2022 | |
| Spinal Simplicity, LLC | $217.00 | 2025 | Ha Minuteman G3-R |
| Lilly USA, LLC | $166.97 | 2019-2024 | Emgality, Reyvow |
| Stryker Corporation | $166.85 | 2024-2025 | Mild Device Kit |
| Painteq LLC | $149.43 | 2021-2024 | Painteq |
| Biohaven Pharmaceutical Holding Company LTD. | $146.08 | 2022 | |
| Allergan, INC. | $125.68 | 2020-2021 | |
| Redhill Biopharma INC. | $114.21 | 2020-2022 | |
| Lundbeck LLC | $104.85 | 2022-2025 | Vyepti |
| Medtronic USA, INC. | $100.94 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $100.76 | 2024-2025 | Gel-One Cross-Linked Hyaluronate |
| Comsort, INC | $100.00 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $99.48 | 2022 | |
| Protega Pharmaceutials INC | $93.55 | 2023-2025 | Roxybond |
| Grt US Holding, INC. | $88.19 | 2021-2022 | |
| Curonix LLC | $85.01 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Vertiflex, INC. | $81.56 | 2019 | |
| Forte Bio-Pharma LLC | $76.37 | 2020-2021 | |
| Axsome Therapeutics, INC. | $69.40 | 2025 | Symbravo |
| Kowa Pharmaceuticals America, INC. | $66.02 | 2022-2023 | Seglentis |
| Fidia Pharma USA INC. | $63.51 | 2019-2023 | Triluron |
| Stimwave Technologies Incorporated | $61.41 | 2020-2022 | |
| Amneal Pharmaceuticals LLC | $60.33 | 2023 | Lyvispah |
| Almatica Pharma LLC | $57.40 | 2021-2022 | |
| Azurity Pharmaceuticals, INC. | $47.56 | 2023-2024 | Horizant, Horizant |
| Currax Pharmaceuticals LLC | $43.60 | 2020 | |
| Avanos Medical | $42.52 | 2024 | Generator |
| Trevena, INC. | $36.90 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $36.66 | 2021 | |
| Amgen INC. | $35.09 | 2020-2022 | |
| Radius Health, INC. | $35.01 | 2019-2020 | |
| Bioventus LLC | $34.16 | 2021 | |
| Virtus Pharmaceuticals LLC | $30.04 | 2021 | |
| Supernus Pharmaceuticals, INC. | $29.49 | 2019-2021 | |
| Globus Medical, INC. | $29.12 | 2025 | Senza |
| Arbor Pharmaceuticals, INC. | $27.40 | 2021-2022 | |
| Si-Bone, INC. | $27.19 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.12 | 2019 | |
| Neurocrine Biosciences, INC. | $24.01 | 2024 | Ingrezza |
| Nalu Medical, INC. | $22.45 | 2024 | Nalu Neurostimulation System |
| Pacira Pharmaceuticals Incorporated | $20.54 | 2023 | Zilretta, Iovera, Exparel |
| Relievant Medsystems, INC. | $19.60 | 2022 | |
| Indivior INC. | $17.55 | 2025 | Sublocade |
| Acelrx Pharmaceuticals, INC. | $17.29 | 2019 | |
| Siemens Medical Solutions USA, INC. | $14.57 | 2022 | |
| Merck Sharp & Dohme LLC | $13.94 | 2019 | |
| Orexo US, INC. | $13.41 | 2019 | |
| Horizon Therapeutics Plc | $11.77 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Sasso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.